Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pharmakon Labs

This article was originally published in The Tan Sheet

Executive Summary

Pharmakon Labs: Orasept oral anesthetic, antiseptic and astringent contains tannic acid, which is not GRAS/E as a cold sore and fever blister treatment ingredient, rendering the product mislabeled, FDA told the firm in a recent warning letter. However, "even without the presence of tannic acid in the formulation for Orasept, the product is a `new drug' because of claims for gingivitis and herpes simplex cold sores found in the labeling" and is misbranded because it fails to bear adequate directions for use, the agency notes...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085954

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel